Pooled human
immunoglobulin labeled with
indium-111 (111In-HIgG) was used to identify the presence and extent of
infection in patients positive for human immunodeficiency virus (HIV), presenting with either symptoms and/or signs of acute chest
infection or with
pyrexia without localizing signs or symptoms. Fifty-five studies were performed in 51 patients with suspected chest
infection or
pyrexia without localizing signs. Of these, 111In-HIgG identified intrapulmonary accumulation in 17 patients with
Pneumocystis carinii pneumonia, eight with
bacterial pneumonia, five with cytomegalovirus
pneumonia, three with pulmonary
Mycobacterium avium intracellulare infection and one with a fungal
pneumonia. There was no intrapulmonary accumulation of 111In-HIgG in five patients with bronchopulmonary
Kaposi's sarcoma and in three patients with intrathoracic
lymphoma. Quantification of lung/heart activity was significantly increased (p < 0.05) in patients with active chest
infection compared with those with intrapulmonary
tumor or no active lung pathology. Indium-111-HIgG scintigraphy also localized at 14 sites of extrapulmonary
infection, including six patients with
colitis. There were no false-negative studies but false-positive uptake was seen in four studies. These results confirm that 111In-HIgG correctly identifies the presence and extent of
infection in patients positive for HIV antibody.